On June 7, 2021 Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, reported that the Company will present at the Lytham Partners Summer 2021 Investor Conference (Press release, Lipocine, JUN 7, 2021, View Source [SID1234583686]). The conference will be held virtually. Presentation details are below.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Lytham Partners Summer 2021 Investor Conference June 14-16
Presentation time:
June 14, 2021 starting at 3:30 PM ET
Webcast link:
The webcast of this presentation will also be available on Lipocine’s corporate website under "Events & Presentations" in the Investors section.